September/October
1999
Vol
6, No 5 CME Pretest
In this issue, selected new
paradigms in anticancer drugs are persented. First, answer the pretest questions
below. After reading the articles, proceed with answering the CME posttest questions.
This Journal
provides 4 hours of Category 1 Continuing Medical Education
Complimentary CME Credits
Physicians can earn 4 credit
hours of Category 1 for the Physician's Recognition Award of the American Medical
Association by reading the material in this issue and successfully answering
the questions in the posttest at the end of this issue. Complete instructions
are given on the posttest pages. Successfully answering 30 or more questions
will earn 4 credit hours. CME is presented by an unrestricted educational grant
from Bristol-Myers Squibb Oncology Division.
Educational Objectives
After reading this issue
of Cancer Control, clinicians will be expected to:
- understand signal transduction,
- be aware of the roles
of angiogenesis and angiogenesis inhibitors in cancer,
- recognize changes in
pharmacology that are age-dependent,
- appreciate the significance
of palliative end-points in clinical trials, and
- know the risk of infection
in transfused red blood cells.
This program was planned in
accordance with ACCME Essentials.
Release Date: September
1, 1999
Expiration Date: September 1, 2000
Pretest